Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer Discussion
Publication
, Journal Article
Wise, P; Efron, J; Foley, EF; Migaly, J
Published in: JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
April 1, 2018
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
EISSN
1879-1190
ISSN
1072-7515
Publication Date
April 1, 2018
Volume
226
Issue
4
Start / End Page
678 / +
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wise, P., Efron, J., Foley, E. F., & Migaly, J. (2018). Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer Discussion. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 226(4), 678-+.
Wise, Paul, Jonathan Efron, Eugene F. Foley, and John Migaly. “Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer Discussion.” JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS 226, no. 4 (April 1, 2018): 678-+.
Wise P, Efron J, Foley EF, Migaly J. Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer Discussion. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 2018 Apr 1;226(4):678-+.
Wise, Paul, et al. “Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer Discussion.” JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, vol. 226, no. 4, ELSEVIER SCIENCE INC, Apr. 2018, pp. 678-+.
Wise P, Efron J, Foley EF, Migaly J. Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer Discussion. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC; 2018 Apr 1;226(4):678-+.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
EISSN
1879-1190
ISSN
1072-7515
Publication Date
April 1, 2018
Volume
226
Issue
4
Start / End Page
678 / +
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences